Grace Colon Care Dx, Inc. (CDNA) insider trading activity

CDNA Quotes by TradingView

Grace Colon is Director of CareDx, Inc.. Currently has a direct ownership of 23,708 shares of CDNA, which is worth approximately $524,658. The most recent transaction as insider was on Jun 16, 2023, when has been sold 18,844 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.7K
0% 3M change
0% 12M change
Total Value Held $524,658

Grace Colon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2023
BUY
Grant, award, or other acquisition
-
18,844 Added 44.28%
23,708 Common Stock
Aug 10 2022
SELL
Open market or private sale
$62,546 $24.81 p/Share
2,521 Reduced 34.14%
4,864 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
4,863 Added 39.7%
7,385 Common Stock
May 11 2022
SELL
Open market or private sale
$119,169 $23.01 p/Share
5,179 Reduced 67.25%
2,522 Common Stock
Mar 09 2022
SELL
Open market or private sale
$48,142 $34.56 p/Share
1,393 Reduced 15.32%
7,701 Common Stock
Jun 16 2021
BUY
Grant, award, or other acquisition
-
1,127 Added 11.03%
9,094 Common Stock

Also insider at

VYGR
Voyager Therapeutics, Inc. Healthcare
Director
GC

Grace Colon

Director
Brisbane, CA

Track Institutional and Insider Activities on CDNA

Follow CareDx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDNA shares.

Notify only if

Insider Trading

Get notified when an Care Dx, Inc. insider buys or sells CDNA shares.

Notify only if

News

Receive news related to CareDx, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CDNA